Antibody recognition of aberrant glycosylation on the surface of cancer cells

•Several carbohydrate antigens are being considered for antibody-based cancer immunotherapies.•Crystallography has revealed many aspects of antibody recognition of tumor-associated glycans.•Computational and binding data has been key to dissecting several antibody–glycan interactions.•The structural basis for antibody activity at the surface of cancer cells requires further study.